JP2599947B2 - ペプチド化合物 - Google Patents

ペプチド化合物

Info

Publication number
JP2599947B2
JP2599947B2 JP62506666A JP50666687A JP2599947B2 JP 2599947 B2 JP2599947 B2 JP 2599947B2 JP 62506666 A JP62506666 A JP 62506666A JP 50666687 A JP50666687 A JP 50666687A JP 2599947 B2 JP2599947 B2 JP 2599947B2
Authority
JP
Japan
Prior art keywords
cys
group
asp
integer
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62506666A
Other languages
English (en)
Japanese (ja)
Other versions
JPH02500517A (ja
Inventor
ラエルム，オーレ・デイドリク
Original Assignee
ニユコメド・アクシエセルカペト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニユコメド・アクシエセルカペト filed Critical ニユコメド・アクシエセルカペト
Publication of JPH02500517A publication Critical patent/JPH02500517A/ja
Application granted granted Critical
Publication of JP2599947B2 publication Critical patent/JP2599947B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP62506666A 1986-11-06 1987-11-05 ペプチド化合物 Expired - Lifetime JP2599947B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626539A GB8626539D0 (en) 1986-11-06 1986-11-06 Peptide compounds
GB8626539 1986-11-06

Publications (2)

Publication Number Publication Date
JPH02500517A JPH02500517A (ja) 1990-02-22
JP2599947B2 true JP2599947B2 (ja) 1997-04-16

Family

ID=10606897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62506666A Expired - Lifetime JP2599947B2 (ja) 1986-11-06 1987-11-05 ペプチド化合物

Country Status (15)

Country Link
US (1) US4987122A (enExample)
EP (2) EP0267741B1 (enExample)
JP (1) JP2599947B2 (enExample)
AT (1) ATE77628T1 (enExample)
AU (1) AU604279B2 (enExample)
CA (1) CA1337407C (enExample)
DE (1) DE3780000T2 (enExample)
ES (1) ES2038675T3 (enExample)
FI (1) FI92209C (enExample)
GB (1) GB8626539D0 (enExample)
GR (1) GR3005557T3 (enExample)
IE (1) IE59342B1 (enExample)
NZ (1) NZ222466A (enExample)
WO (1) WO1988003535A1 (enExample)
ZA (1) ZA878349B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO884054D0 (no) * 1988-09-13 1988-09-13 Bio Tech As Nytt pentapeptid og fremgangsmaate for fremstilling derav.
GB8821785D0 (en) * 1988-09-16 1988-10-19 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides
HU206372B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same
DK53191D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211668D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
US5610141A (en) * 1992-06-02 1997-03-11 Nycomed Imaging As Double chain peptide compounds having hemoregulatory activity
US6764693B1 (en) 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
JP4006021B2 (ja) * 1993-06-08 2007-11-14 スミスクライン・ビーチャム・コーポレイション ケモカインの生物学的活性の強化法
GB9314200D0 (en) * 1993-07-09 1993-08-18 Hafslund Nycomed As Peptide compounds
DE69420044T2 (de) * 1993-10-29 2000-03-23 Smithkline Beecham Corp., King Of Prussia Blutregulierende peptide
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
US6054465A (en) * 1995-11-13 2000-04-25 Smithkline Beecham Corporation Hemoregulatory compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77875C (fi) * 1982-11-26 1989-05-10 Nyegaard & Co As Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptider.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ｅｘｐｅｒｉｍｅｎｔａｌ Ｈｅｍａｔｏｌｏｇｙ，Ｖｏｌ．１２，Ｎｏ．１，（１９８４）Ｐ．７−Ｐ．１７

Also Published As

Publication number Publication date
DE3780000T2 (de) 1993-02-04
AU604279B2 (en) 1990-12-13
WO1988003535A1 (en) 1988-05-19
ATE77628T1 (de) 1992-07-15
EP0267741B1 (en) 1992-06-24
GB8626539D0 (en) 1986-12-10
FI92209B (fi) 1994-06-30
FI92209C (fi) 1994-10-10
ES2038675T3 (es) 1993-08-01
ZA878349B (en) 1988-05-03
US4987122A (en) 1991-01-22
FI892185A0 (fi) 1989-05-05
EP0330667A1 (en) 1989-09-06
CA1337407C (en) 1995-10-24
FI892185L (fi) 1989-05-05
DE3780000D1 (de) 1992-07-30
NZ222466A (en) 1990-09-26
AU8174787A (en) 1988-06-01
GR3005557T3 (enExample) 1993-06-07
JPH02500517A (ja) 1990-02-22
IE872983L (en) 1988-05-06
IE59342B1 (en) 1994-02-09
EP0267741A1 (en) 1988-05-18

Similar Documents

Publication Publication Date Title
CA1236786A (en) Peptide compounds
US4987122A (en) Peptide compounds and medical method of use thereof
EP2611825B1 (en) Solid phase synthesis of h(gly2)glp-2
JPH03118330A (ja) フイブリノーゲンレセプター拮抗剤
AU641366B2 (en) Peptide compounds
CA2020838C (en) Hemoregulatory peptides
JPS62116595A (ja) 新規化合物、その製法及びそれを含む医薬組成物
EP0722459B1 (en) Hemoregulatory penta- or hexapeptides
DK171992B1 (da) Peptider, farmaceutiske præparater indeholdende dise peptider, anvendelse af peptiderne til fremstilling af et farmaceutisk præparat til anvendelse ved stimulering af myelopoieesesystemet hos mennesker eller dyr, fremgansmåde til fremstilling af peptiderne og forbindelser med anvendelse som mellemprodukter herved
US5731289A (en) Double-chain hemoregulatory peptides
US5776900A (en) Hemoregulatory peptides
JPH09278669A (ja) 腎炎治療薬
CA1180006A (en) Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
LT3615B (en) Peptide compounds, method for the preparation and use thereof
JPH07278191A (ja) 新規ペプチドもしくは蛋白質及びそれを探索する方法
HK1187354B (en) Solid phase synthesis of h(gly2)glp-2